NCT01255176

Brief Summary

It gave a clinical trial which will be included in the 60 infants, aged up to 24 months, diagnosed with congenital's population will be divided by simple randomization into three groups: 20 infants in the intervention group, 20 infants in the control group, not receive the RTA technique and another 20 infants in a placebo group, we just get the support manual therapist for 5 minutes. Initially the data will be collected cardio heart rate, respiratory rate and oxygen saturation. Then the researcher will apply three specific rating scales, based on clinical presentation and behavior of infants. Hypothesis: The RTA improves cardiorespiratory parameters and reduces signs of discomfort and pain of infants with congenital heart acyanogenic.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 7, 2010

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Last Updated

June 19, 2013

Status Verified

December 1, 2010

Enrollment Period

1.9 years

First QC Date

December 6, 2010

Last Update Submit

June 18, 2013

Conditions

Keywords

InfantPhysical Therapy

Outcome Measures

Primary Outcomes (2)

  • Changes in cardiorespiratory parameters

    15 minutes after the end of the intervention

  • Pain Scales (NIPS, PIPP, NFCS)

    Immediately after intervention and 15 minutes after the end of the intervention

Study Arms (3)

placebo group

NO INTERVENTION

not receive physical therapy intervention, there will only support the achievement of a handbook on the abdomen of the baby.

control group

NO INTERVENTION

not receive any type of intervention, and infants remain at rest

Thoracoabdominal rebalancing

EXPERIMENTAL

infants who receive physical therapy through the application of the handlings of the RTA.

Procedure: Thoracoabdominal rebalancing

Interventions

In this group the infants received four handlings thoracoabdominal rebalancing, in order: 1) 5min support thoracoabdominal, in which the therapist leaned one hand on the lower chest and upper abdomen of the newborn, with some of its fingers on the ribs, pulling them gently down and keeping them in that position during inspiration, 2) more than 5 minutes of abdominal support, carried by hand in the lower abdomen of the newborn, applying light pressure during inspiration enough to be beaten by the diaphragm of the newborn and not to increase the use of accessory muscles of inspiration, 3) 5min support ileo-costal, by a slight manual pressure of the physiotherapist on the lateral chest and abdomen of the newborn, maintained throughout inspiration and 4) finally ran up 5min ginga thoracic maneuver slight manual pressure on the lower chest of newborns, directing the costal movement during expiration, now an then the other hemithorax.

Thoracoabdominal rebalancing

Eligibility Criteria

Age1 Day - 24 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Newborns admitted to the nursery without ventilatory support or oxygen therapy, and whose parents agree with the child's participation in the study. Will be excluded newborns who have some problems during any of the study procedures and those whose condition will change after the intervention, with shift in ventilatory support or oxygen therapy.

You may not qualify if:

  • In case of inability to collect some of the parameters evaluated at the appropriate time, the RN also will no longer part of the sample, as well as those who show no contraindication to therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Joana de Gusmão Children's Hospital

Florianópolis, Santa Catarina, Brazil

Location

Study Officials

  • Camila Schivinski, Doctor

    Professor of Universidade do Estado de Santa Catarina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

December 6, 2010

First Posted

December 7, 2010

Study Start

January 1, 2010

Primary Completion

December 1, 2011

Last Updated

June 19, 2013

Record last verified: 2010-12

Locations